MP0DPIL0TX
Pilot Holder Expansion Kit
For Pod configurations up to 5.5 m2
Select a Size
Select a Size
About This Item
Recommended Products
Quality Level
fitting
1.5 in. gauge port sanitary flange
1.5 in. inlet/outlet sanitary flange
compatibility
for use with Pod Filters
Related Categories
1 of 4
This Item | C6745 | C8374 | C5533 |
|---|---|---|---|
| technique(s) cell culture | mammalian: suitable | technique(s) cell culture | mammalian: suitable | technique(s) cell culture | stem cell: suitable | technique(s) cell culture | mammalian: suitable |
| concentration 1 mg/mL | concentration 0.3 mg/mL | concentration - | concentration - |
| assay 95% (Human collagen type IV, SDS-PAGE) | assay - | assay >85% (SDS-PAGE) | assay - |
| Quality Level 100 | Quality Level 200 | Quality Level 200 | Quality Level 200 |
| form liquid | form solution | form powder | form powder |
Application
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.
A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.
Learn more one the attenuated viral vaccines manufacturing process: cell culture, clarification, nuclease treatment, chromatography, and sterile filtration.
This technical article breaks down the steps of upstream and downstream bioprocessing and formulation of virus-like particle vaccines.
Related Content
This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
